Direct carbon isotope exchange of pharmaceuticals via reversible decyanation - CEA - Commissariat à l’énergie atomique et aux énergies alternatives
Article Dans Une Revue Journal of the American Chemical Society Année : 2021

Direct carbon isotope exchange of pharmaceuticals via reversible decyanation

Résumé

The incorporation of carbon-14 allows tracking of organic molecules and provides vital knowledge on their fate. This information is critical in pharmaceutical development, crop science, and human food safety evaluation. Herein, a transition-metal-catalyzed procedure enabling carbon isotope exchange on aromatic nitriles is described. By utilizing the radiolabeled precursor Zn([$^{14}$C]CN)$_2$, this protocol allows the insertion of the desired carbon tag without the need for structural modifications, in a single step. By reducing synthetic costs and limiting the generation of radioactive waste, this procedure will facilitate the labeling of nitrile containing drugs and accelerate 14C-based ADME studies supporting drug development.
Fichier principal
Vignette du fichier
Manuscript.pdf (1.43 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

cea-03204990 , version 1 (23-05-2024)

Identifiants

Citer

Minghao Feng, Joao de Oliveira, Antoine Sallustrau, Gianluca Destro, Pierre Thuéry, et al.. Direct carbon isotope exchange of pharmaceuticals via reversible decyanation. Journal of the American Chemical Society, 2021, 143 (15), pp.5659-5665. ⟨10.1021/jacs.1c01923⟩. ⟨cea-03204990⟩
197 Consultations
57 Téléchargements

Altmetric

Partager

More